EW
Edwards Lifesciences Corporation
NYSE · Healthcare · Medical - Devices · US
$89.71
−0.08%Forward multiples
Based on analyst estimates
- P/E forward
- 28.50x
- P/E 2026E
- 29.97x
- P/E 2027E
- 26.57x
- P/E 2028E
- 23.70x
- P/S forward
- 7.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- 51.55x
- PEG TTM
- 0.64x
- Price / book
- 4.87x
- Price / sales
- 7.94x
- Price / cash flow
- 30.06x
Enterprise value
- Enterprise value
- $48.3B
- EV / sales
- 7.41x
- EV / EBITDA
- 31.34x
- EV / EBIT
- 26.38x
- Market cap
- $51.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026